Literature DB >> 15370197

Apolipoprotein E polymorphism and stroke in a population from eastern Turkey.

Selma Duzenli1, Ibrahim Pirim, Akcahan Gepdiremen, Orhan Deniz.   

Abstract

Human apolipoprotein E (apo E) alleles are polymorphic with significantly different frequencies among different ethnic groups and have been associated with increased risk of coronary heart disease, and postulated as a major genetic susceptibility locus for Alzheimer's disease. Studies undertaken in different populations have shown different association patterns between apo E genotype and stroke. The aim of this study was to determine the risk of apo E genotype in stroke patients living in the eastern part of Turkey. The apo E genotypes and allele frequencies of 229 individuals from the same geographic area were determined by polymerase chain reaction and restriction fragment length polymorphism, of which 103 were patients with a documented history of stroke without other apparent dementia and 126 age-matched healthy subjects as a control group. A reduced E3/4 genotype frequency was found in subjects with stroke and the E2/3 genotype frequency was elevated in patients with previous stroke. There was no association between apo E epsilon4 allele and stroke. The APOE alleles had divergent effects in this population. Association between APOE (the gene) alleles and stroke in this population may be altered due to interaction with other genetic effects. The effects of APOE alleles and genotypes require further study in different populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370197     DOI: 10.1080/01677060490500294

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  6 in total

1.  Association of APOE Gene Polymorphism with Stroke Patients from Rural Eastern India.

Authors:  Hilal Ahmad Ganaie; Arindam Biswas; Annada Prasad Bhattacharya; Sandip Pal; Jharna Ray; Shymal Kumar Das
Journal:  Ann Indian Acad Neurol       Date:  2019-07-10       Impact factor: 1.383

2.  Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Authors:  Alessandro Biffi; Akshata Sonni; Christopher D Anderson; Brett Kissela; Jeremiasz M Jagiella; Helena Schmidt; Jordi Jimenez-Conde; Björn M Hansen; Israel Fernandez-Cadenas; Lynelle Cortellini; Alison Ayres; Kristin Schwab; Karol Juchniewicz; Andrzej Urbanik; Natalia S Rost; Anand Viswanathan; Thomas Seifert-Held; Eva-Maria Stoegerer; Marta Tomás; Raquel Rabionet; Xavier Estivill; Devin L Brown; Scott L Silliman; Magdy Selim; Bradford B Worrall; James F Meschia; Joan Montaner; Arne Lindgren; Jaume Roquer; Reinhold Schmidt; Steven M Greenberg; Agnieszka Slowik; Joseph P Broderick; Daniel Woo; Jonathan Rosand
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

3.  Apolipoprotein E ε4 Polymorphism as a Risk Factor for Ischemic Stroke: A Systematic Review and Meta-Analysis.

Authors:  Su-Ya Qiao; Ke Shang; Yun-Hui Chu; Hai-Han Yu; Xin Chen; Chuan Qin; Deng-Ji Pan; Dai-Shi Tian
Journal:  Dis Markers       Date:  2022-02-03       Impact factor: 3.434

4.  Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis.

Authors:  Lian Gu; Li Su; Qing Chen; Baoyun Liang; Yuwang Qin; Juanjuan Xie; Guangliang Wu; Yan Yan; Jianxiong Long; Huayu Wu; Jinjing Tan; Weihua Dou; Wei Chen; Peng Wu; Jinping Wang
Journal:  Exp Ther Med       Date:  2012-12-19       Impact factor: 2.447

5.  The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults.

Authors:  George Peck; Liam Smeeth; John Whittaker; Juan Pablo Casas; Aroon Hingorani; Pankaj Sharma
Journal:  PLoS One       Date:  2008-11-14       Impact factor: 3.240

6.  Apolipoprotein E polymorphism and the risk of aneurysmal subarachnoid hemorrhage in a South Indian population.

Authors:  Arati Suvatha; Sibin Madathan Kandi; Dhananjaya Ishwara Bhat; Narasinga Rao; Vikas Vazhayil; Chetan Ghati Kasturirangan
Journal:  Cell Mol Biol Lett       Date:  2017-11-29       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.